All In Biotech

Drug Trial Radar · NCT07158112

Assessing Gingivitis and Plaque From a Marketed Toothpaste

A Randomized Three-Month Clinical Trial Evaluating Anti-Gingivitis Efficacy of Stannous Fluoride Dentifrices Relative to a Negative Control

Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 120 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

120

Actual

Start

Aug 30, 2025

Primary completion

Dec 7, 2025

Study completion Dec 7, 2025

Sponsor

Lead sponsor
Procter and GambleIndustry
Sponsor type
Industry
First posted
Sep 5, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The primary objective of this study is to evaluate the effect of two 0.454% stannous fluoride dentifrices on gingivitis relative to a negative control (Colgate® Cavity Protection toothpaste) and the comparative anti-gingivitis efficacy of the two 0.454% SnF2 dentifrices after 12 weeks of product use.

Conditions

  • Gingivitis

Interventions

  • Stannous Fluoride DentifriceDrug

    Each subject will be randomly assigned to one of three treatment products and will be asked to brush 2x a day (1 minute per brushing) for 3 months.

  • Test Stannous Fluoride DentifriceDrug

    Each subject will be randomly assigned to one of three treatment products and will be asked to brush 2x a day (1 minute per brushing) for 3 months.

  • Sodium monofluorophosphate dentifriceDrug

    Each subject will be randomly assigned to one of three treatment products and will be asked to brush 2x a day (1 minute per brushing) for 3 months.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Bleeding SitesTime frame: 1 month and 3 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University Health Resources Group

    Whitter, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.